Oie Sangyo Co Ltd
Oie Sangyo Co Ltd maintains a strong liquidity position, with a current ratio of 1.2 and cash and equivalents amounting to ¥3.99 billion, which supports its short-term obligations. The company's low debt-to-equity ratio of 0.03 indicates a conservative capital structure, with minimal reliance on long-term debt. Profitability metrics show a healthy balance, with a tangible book value of ¥12.69 billion and a price-to-book ratio of 1.57, suggesting the company is valued in line with its tangible assets. The operating cash flow of ¥2.81 billion supports ongoing operations and reinvestment. The company's revenue is primarily concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification. This concentration may expose the company to regional economic fluctuations, though the lack of disclosed geographic breakdown limits further analysis. Growth trajectory appears stable, with the most recent actual revenue reported at ¥119.26 billion. While no forward-looking revenue growth rates are provided, the company's consistent operating cash flow and low debt suggest a stable financial foundation. Risk factors are minimal, with low liquidity and dilution risk identified. No immediate filing-based liquidity or dilution flags were detected, and the company's capital structure remains stable with no dilution potential in the near term. Recent events include the latest actual EPS of ¥339.57 and revenue of ¥119.26 billion, as reported in the most recent financial filings. No significant new developments or regulatory changes have been disclosed in the latest available data.
Business. Oie Sangyo Co Ltd operates in the Food & Drug Retailing sector, primarily generating revenue through the retail and distribution of food and drug products.
Classification. Oie Sangyo Co Ltd is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a classification confidence of 0.92.
- Oie Sangyo Co Ltd maintains a conservative capital structure with low debt and strong liquidity.
- The company's valuation is in line with its tangible book value, indicating a stable market perception.
- Revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification.
- Growth appears stable, supported by consistent operating cash flow and low financial leverage.
- No immediate liquidity or dilution risks are present, and the company's risk profile is favorable.
- --
- ## RATIONALES
- ```json
- No immediate filing-based liquidity or dilution flags were detected.